Literature DB >> 2243652

The Nelson general practice prescribing project. Part I: A pilot audit of the regional prescribing profile.

R I Ferguson1, T J Maling.   

Abstract

The Nelson general practice prescribing project has been set up to develop a model for cost effective prescribing in general practice. A pilot audit of regional prescribing patterns and trends for February 1989 was conducted to test data acquisition and presentation for the project, based on 12,690 scripts. There was marked variation in medicines choice, cost and number of scripts between general practitioners. The cost of prescriptions ranged from $2.20 to $127.70, median $10.77. Cardiovascular medicines were most frequently prescribed and most costly. Extemporaneous prescribing accounted for 20% of the February inventory and was highly individually variable. Benzodiazepine prescribing was not in line with current guidelines and was high, mean 6.7% of all prescribing, indicating an urgent need for unbiased drug information. Audited prescription data allows definitions of educational and pricing strategies.

Entities:  

Mesh:

Year:  1990        PMID: 2243652

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  5 in total

1.  Economic constraints and prescribing patterns in New Zealand.

Authors:  G S Kellaway
Journal:  Pharmacoeconomics       Date:  1992-09       Impact factor: 4.981

2.  The New Zealand preferred medicines concept: a national scheme for audit and quality assurance of prescribing.

Authors:  T J Maling
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

3.  A review of limited lists and formularies: are they cost-effective?

Authors:  M J Pearce; E J Begg
Journal:  Pharmacoeconomics       Date:  1992-03       Impact factor: 4.981

4.  The Nelson Prescribing Project. A programmed intervention in general practice in New Zealand.

Authors:  R I Ferguson; C E Salmond; T J Maling
Journal:  Pharmacoeconomics       Date:  1995-06       Impact factor: 4.981

5.  Reflections on a month in the life of the Ontario Drug Benefit Plan.

Authors:  W McIsaac; C D Naylor; G M Anderson; B J O'Brien
Journal:  CMAJ       Date:  1994-02-15       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.